Bio
We contribute to the healthy lives of humankind through vaccines, new drugs, and etc.
SK is
leaping forward as a global bio company with vaccine and new drugs development and consigned development of pharmaceutical products (contract manufacturing organization [CMO]) and more.
By developing drugs and pharmaceuticals that benefit the world, we will provide solutions for humankind’s well-being.
By developing drugs and pharmaceuticals that benefit the world, we will provide solutions for humankind’s well-being.
Details of Bio
Stable growth of composite raw material pharmaceuticals area
In the drug consignment development and production (contract development and manufacturing organization [CDMO]) area, we are facilitating extra facilities and technological base growth of application programming interface (API) business while nurturing future growth engine by establishing an integrated global operation system of capital gains tax (CGT) businesses.
Establishing the future foundation of the pharmaceutical business
While creating strategic synergy of bio portfolio within the group’s pharmaceutical businesses, we are also looking for companies with potential technologies and laying a foundation for growth with preemptive investments in promising areas.
Value-up: Continued creation of pipelines
In the composite raw material medicine area, we are seeking to expand next-generation technology (antibody-drug conjugate [ADC], oligonucleotide)-based production. In addition, based on the existing capabilities of the pharmaceutical area, we aim to continuously create pipelines by adding value to the portfolio that focuses on the development of new drugs.
We make humankind healthy and happy with
solutions that never existed before.
View more stories of SK employees
solutions that never existed before.
